COVID-19: Expected challenges and risks to blood safety

Asia Pacific Blood Network Rapid Brief White Paper, prepared: 17th February 2020

Executive Summary: The novel coronavirus that emerged in 2019 (SARS-CoV-2) in China is a significant new public health threat in the Asia-Pacific region. Whilst there are considerable information gaps at this time, experience with similar respiratory coronaviruses (SARS-CoV and MERS-CoV) suggest that SARS-CoV-2 has the ability to impact significantly on blood supply through donor deferrals, illness, public health requirements of quarantine and reduced staff and donor availability. SARS-CoV-2 has not been confirmed as transfusion-transmissible, and viraemia has only been detected in unwell patients who would not be eligible to donate blood. Options to decrease the risk of transfusion transmission of SARS-CoV-2 include exclusion of at risk donors, quarantine of blood components, pathogen reduction or testing. The appropriate risk reduction strategy needs to take into account the local epidemiology, risk of transfusion-transmission in the context of the overall burden of disease, the public health response, blood supply sufficiency, operational impacts and cost considerations. Given that the infectious risk to blood safety is theoretical, any precautionary exclusion of at risk donors should be regularly re-evaluated with further information as the epidemic progresses. On the other hand, blood product sufficiency due to decreased availability of donors is a significant potential or real risk where local transmission is widespread and blood services should consider the sufficiency risk early to enable preparedness and response.

Are you sure you want to delete this "resource"?
This item will be deleted immediately. You cannot undo this action.

Related Resources

Guidance material
15 May 2020
Impliquer les migrants et les personnes déplacées dans les activités de préparation et de réponse à la pandémie de COVID-19 Lignes directrices à l’intention des Sociétés nationales de la région du Sahel – version 1.0 (20 mars 2020) Inc...
Tags: Guidance material, COVID-19 (Coronavirus)
Guidance material
06 Apr 2021
Global Advisory Panel (GAP) guidance on COVID 19 vaccinations and blood donation
Tags: Guidance material, COVID-19 (Coronavirus)
Guidance material
22 Sep 2020
Community-based health care, including outreach and campaigns, in the context of the COVID-19 pandemic. Interim guidance developed by the IFRC, UNICEF, and WHO.
Tags: Guidance material, COVID-19 (Coronavirus)